Doxorubicin/eribulinLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2044卷 / 1期

关键词：

D O I：

10.1007/s40278-025-75796-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：130 / 130

相关论文

共 50 条

[21] Doxorubicin/ifosfamide/pembrolizumabLack of efficacy: case report
Reactions Weekly, 2022, 1918 (1) : 200 - 200
[22] Cyclophosphamide/doxorubicin/paclitaxelLack of efficacy: case report
Reactions Weekly, 2023, 1974 (1) : 121 - 121
[23] Doxorubicin-liposomalLack of efficacy: case report
Reactions Weekly, 2022, 1924 (1) : 198 - 198
[24] Doxorubicin/ifosfamide/mesnaLack of efficacy: case report
Reactions Weekly, 2024, 2039 (1) : 190 - 190
[25] Cisplatin/doxorubicin/ifosfamideLack of efficacy: case report
Reactions Weekly, 2025, 2047 (1) : 122 - 122
[26] Doxorubicin/ifosfamide/selumetinibLack of efficacy : case report
Reactions Weekly, 2024, 2020 (1) : 182 - 182
[27] Doxorubicin/ifosfamideToxicity and lack of efficacy: case report
Reactions Weekly, 2022, 1935 (1) : 185 - 185
[28] Cyclophosphamide/doxorubicin/vincristineLack of efficacy: case report
Reactions Weekly, 2024, 2032 (1) : 143 - 143
[29] Cisplatin/doxorubicin/fluorouracilLack of efficacy: case report
Reactions Weekly, 2022, 1904 (1) : 145 - 145
[30] Cisplatin/doxorubicin/ifosfamideLack of efficacy: case report
Reactions Weekly, 2023, 1966 (1) : 118 - 118

← 1 2 3 4 5 →